Streetbeat News

Analyst Ratings

RCKT

Needham analyst Gil Blum reiterates a Buy rating on Rocket Pharmaceuticals (NASDAQ:RCKT) and maintains a $60 price target.

Portfolio Pulse from richadhand@benzinga.com

May 23, 2023 | 4:10 pm

IMVT

HC Wainwright & Co. analyst Douglas Tsao maintains a Buy rating on Immunovant (NASDAQ:IMVT) and raises the price target from $26 to $27.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 4:10 pm

QTRX

Goldman Sachs upgraded Quanterix Corp (NASDAQ:QTRX) from Neutral to Buy and raised the price target from $13 to $27. Quanterix, a leader in the neurology diagnostics market, has a strong technology platform in Simoa and could play an important role in the blood-based Alzheimer's diagnostics market.

Portfolio Pulse from Priya Nigam

May 23, 2023 | 4:09 pm

AMD

Advanced Micro Devices (NASDAQ:AMD) has received 20 analyst ratings in the last quarter, with an average price target of $115.05, representing an upside from the current price of $109.495. The current average has increased by 19.41% from the previous average price target of $96.35.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 4:06 pm

VZIO

Analysts have provided ratings for VIZIO Holding (NYSE:VZIO) within the last quarter, with an average price target of $12.86, representing an upside from the current price of $7.11. The current average represents a 15.67% decrease from the previous average price target of $15.25.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 4:06 pm

WPM

In the last 3 months, 4 analysts have provided 12-month price targets for Wheaton Precious Metals (NYSE:WPM), with an average target of $49.75. The average price target has increased by 5.85% over the past month.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 4:04 pm

ANIX

In the last quarter, Anixa Biosciences (NASDAQ:ANIX) received 6 bullish analyst ratings. The average 12-month price target for the stock is $10.83, up 14% from the previous average of $9.50.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 4:03 pm

CRM

A large bearish position on Salesforce (NYSE:CRM) has been spotted, with 72% of big-money traders showing bearish sentiment. Whales have been targeting a price range of $65.0 to $237.5 for Salesforce over the last 3 months.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 4:02 pm

PACW

Over the past 3 months, 9 analysts have published their opinion on PacWest Banc (NASDAQ:PACW) stock, with an average 12-month price target of $18.44. The current average has decreased by 15.65% from the previous average price target of $21.86.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 4:01 pm

TPVG

Over the past 3 months, 6 analysts have published their opinion on TriplePoint Venture Gwth (NYSE:TPVG) stock, with an average 12-month price target of $12.33, down 8.67% from the previous average of $13.50.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 4:00 pm